Frailty and Post-hospitalization Outcomes in Patients With Heart Failure With Preserved Ejection Fraction

被引:15
|
作者
Goyal, Parag [1 ]
Yum, Brian [2 ]
Navid, Pedram [1 ]
Chen, Ligong [3 ]
Kim, Dae H. [4 ]
Roh, Jason [5 ]
Jaeger, Byron C. [6 ]
Levitan, Emily B. [3 ]
机构
[1] Weill Cornell Med, Dept Med, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[3] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA
[4] Hebrew SeniorLife, Marcus Inst Aging Res, Boston, MA USA
[5] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA
[6] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL USA
来源
关键词
PREVALENCE; COMORBIDITIES; READMISSION; MODELS; TRENDS;
D O I
10.1016/j.amjcard.2021.02.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Given the role of comorbid conditions in the pathophysiology of HFpEF, we aimed to identify and rank the importance of comorbid conditions associated with post-hospitalization outcomes of older adults hospitalized for HFpEF. We examined data from 4,605 Medicare beneficiaries hospitalized in 2007-2014 for HFpEF based on ICD-9-CM codes for acute diastolic heart failure (428.31 or 428.33). To identify characteristics with high importance for prediction of mortality, all-cause rehospitalization, rehospitalization for heart failure, and composite outcome of mortality or all-cause rehospitalization up to 1 year, we developed boosted decision tree ensembles for each outcome, separately. For interpretability, we estimated hazard ratios (HRs) and 95% confidence intervals (CI) using Cox proportional hazards models. Age and frailty were the most important characteristics for prediction of mortality. Frailty was the most important characteristic for prediction of rehospitalization, rehospitalization for heart failure, and the composite outcome of mortality or all-cause rehospitalization. In Cox proportional hazards models, a 1-SD higher frailty score (0.1 on theoretical range of 0 to 1) was associated with a HR of 1.27 (1.06 to 1.52) for mortality, 1.16 (1.07 to 1.25) for all-cause rehospitalization, 1.24 (1.14 to 1.35) for HF rehospitalization, and 1.15 (1.07 to 1.25) for the composite outcome of mortality or allcause rehospitalization. In conclusion, frailty is an important predictor of mortality and rehospitalization in adults aged >= 66 years with HFpEF. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:84 / 93
页数:10
相关论文
共 50 条
  • [1] The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction)
    Carson, Peter E.
    Anand, Inder S.
    Win, Sithu
    Rector, Thomas
    Haass, Markus
    Lopez-Sendon, Jose
    Miller, Alan
    Teerlink, John R.
    White, Michel
    McKelvie, Robert S.
    Komajda, Michel
    Zile, Michael R.
    McMurray, John J.
    Massie, Barry
    JACC-HEART FAILURE, 2015, 3 (06) : 429 - 441
  • [2] Impact of frailty on outcomes in patients with heart failure with preserved ejection fraction
    Sanders, Natalie
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (11) : 608 - 608
  • [3] Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction
    Malik, Awais
    Gill, Gauravpal S.
    Lodhi, Fahad K.
    Tummala, Lakshmi S.
    Singh, Steven N.
    Morgan, Charity J.
    Allman, Richard M.
    Fonarow, Gregg C.
    Ahmed, Ali
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (01): : 84 - 94
  • [4] FRAILTY INDEPENDENTLY PREDICTS HOSPITALIZATION BURDEN IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Sareini, Mohamed-Ali
    Hornsby, Whitney
    Alreefi, Fadi
    Konerman, Matthew
    Hummel, Scott L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 835 - 835
  • [5] Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Poppe, Katrina K.
    Doughty, Robert N.
    HEART FAILURE CLINICS, 2014, 10 (03) : 503 - +
  • [6] Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    Butt, Jawad H.
    Dewan, Pooja
    Jhund, Pardeep S.
    Anand, Inder S.
    Atar, Dan
    Ge, Junbo
    Desai, Akshay S.
    Echeverria, Luis E.
    Kober, Lars
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Rouleau, Jean L.
    Sim, David
    Van Veldhuisen, Dirk J.
    Vrtovec, Bojan
    Zannad, Faiez
    Zile, Michael R.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Solomon, Scott D.
    McMurray, John J., V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : 1130 - 1143
  • [7] Body mass index, frailty, and outcomes in heart failure with preserved ejection fraction
    Li, Wenjie
    Wang, Zhiyan
    Hua, Chang
    Zhang, Hao
    Liu, Xinru
    Zheng, Shiyue
    Lv, Qiang
    Jiang, Chao
    Dong, Jianzeng
    Ma, Changsheng
    Du, Xin
    ESC HEART FAILURE, 2024, 11 (02): : 709 - 718
  • [8] The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction
    Kinugasa, Yoshiharu
    Yamamoto, Kazuhiro
    HEART, 2017, 103 (03) : 184 - 189
  • [9] Frailty Score Predicts Adverse Outcomes In Ambulatory Heart Failure With Preserved Ejection Fraction
    Trivedi, Rishi K.
    Lee, Zhen J.
    Tian, Jing
    Burns, Jacob
    Hahn, Virginia
    Vaishnav, Joban
    Gerstenblith, Gary
    Buta, Brian
    Xue, Qian-Li
    Sharma, Kavita
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S7 - S7
  • [10] Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
    Solomon, Scott D.
    Claggett, Brian
    Lewis, Eldrin F.
    Desai, Akshay
    Anand, Inder
    Sweitzer, Nancy K.
    O'Meara, Eileen
    Shah, Sanjiv J.
    McKinlay, Sonja
    Fleg, Jerome L.
    Sopko, George
    Pitt, Bertram
    Pfeffer, Marc A.
    EUROPEAN HEART JOURNAL, 2016, 37 (05) : 455 - 462